Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
66.50
-0.05 (-0.08%)
Streaming Delayed Price
Updated: 3:15 PM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
568,078
Open
67.78
Bid (Size)
66.45 (100)
Ask (Size)
66.55 (200)
Prev. Close
66.55
Today's Range
66.16 - 68.26
52wk Range
13.22 - 94.90
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
In a historic moment for the global healthcare industry, Eli Lilly and Company (NYSE:LLY) has officially cemented its position as the world’s first pharmaceutical company to surpass a $1 trillion...
Via
MarketMinute
Topics
Earnings
Economy
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake
↗
February 17, 2026
Structure Therapeutics develops oral therapies for chronic diseases, using a proprietary platform to target G-protein-coupled receptors.
Via
The Motley Fool
Performance
YTD
-2.4%
-2.4%
1 Month
-26.4%
-26.4%
3 Month
+88.4%
+88.4%
6 Month
+258.1%
+258.1%
1 Year
+216.2%
+216.2%
More News
Read More
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
February 06, 2026
Via
MarketMinute
Topics
Earnings
Economy
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals
↗
January 14, 2026
Via
Stocktwits
This Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs.
↗
February 05, 2026
Via
The Motley Fool
A 10% Owner Of Structure Therapeutics Shed Shares
↗
January 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Can This Stock Double Again in 2026?
↗
January 11, 2026
Via
The Motley Fool
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Did Structure Therapeutics Stock Surge Pre-Market Today?
↗
December 08, 2025
Via
Stocktwits
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List
↗
January 05, 2026
Via
Stocktwits
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
The Case for Small-Cap Diversification: Why Investors are Looking Beyond Mega-Cap Tech
December 23, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
December 23, 2025
Via
MarketMinute
Topics
Economy
The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In
December 22, 2025
Via
MarketMinute
Topics
Economy
The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
December 18, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025
December 18, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
December 17, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
December 11, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants
December 09, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Why Structure Therapeutics Stock Doubled and Then Some on Monday
↗
December 08, 2025
Via
The Motley Fool
Global Markets Brace for Fed Decision Amidst Divergent Policies and Geopolitical Crosscurrents
December 09, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
December 08, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
What's going on in today's session
↗
December 08, 2025
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
December 08, 2025
Via
Chartmill
Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
December 08, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
The current price of Structure Therapeutics Inc. - American Depositary Shares is 66.50
When was Structure Therapeutics Inc. - American Depositary Shares last traded?
The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 02/23/26 03:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
